首页> 外国专利> Polymorphic Form b of telmisartan, mixtures of polymorphs of telmisartan, a process for the preparation of telmisartan containing polymorphic form B, and the use of telmisartan to prepare a Medicine

Polymorphic Form b of telmisartan, mixtures of polymorphs of telmisartan, a process for the preparation of telmisartan containing polymorphic form B, and the use of telmisartan to prepare a Medicine

机译:替米沙坦的多晶型物b,替米沙坦的多晶型物的混合物,制备含有多晶型物B的替米沙坦的方法以及替米沙坦在制备药物中的用途

摘要

Forma B polimorfa del cido 4 - 2-n-propil-4-metil-6- (1-metilbencimidazol-2-il) bencimidazol-1-ilmetil -bifenil-2-carbox lico (INN Telmisart n)of formula (1) that is characterized by an endothermic maximum of 183 +/- 2 ° C that manifests itself in thermal analysis using CBD (differential scanning calorimetry). The mixtures of the polymorphic forms A - which was already known in the state of the art - and the polymorphic form B that make up Telmisartan, and the use of the latter to prepare a medicine. A procedure for preparing Telmisartan, which contains the polymorphic form B, in which only form B with its characteristic macroscopic crystalline form is first obtained,When conditions permit, the system remains basically unchanged due to the polymorphism at the end of drying due to the partial change of type B. The procedure includes: (a) mixing the electric mass into a solvent composed of water, folic acid and degradable organic solvent, heating and then filtering the obtained solution; (b) The organic solvent is separated by distillation - finally, it is mixed by a separator using water at the same time;(c) A substrate was added to accelerate the formation of B-type residual solution in electronics; (d) centrifugation, washing and drying.
机译:式B polimorfa del cido 4-式(1)的2-n-propil-4-metil-6-(1-metilbencimidazol-2-il)bencimidazol-1-ilmetil -bifenil-2-carco lico(INN Telmisart n)其特征在于吸热最大值为183 +/- 2°C,这在使用CBD(差示扫描量热法)进行热分析时表现出来。现有技术中已知的多晶型形式A与构成替米沙坦的多晶型形式B的混合物,以及后者用于制备药物的用途。一种制备替米沙坦的方法,该方法包含多晶型物B,其中首先仅获得具有特征性宏观晶型的晶型B。在条件允许的情况下,由于部分干燥导致干燥结束时的多晶型,体系基本保持不变程序包括:(a)将电能混合到由水,叶酸和可降解有机溶剂组成的溶剂中,加热,然后过滤得到的溶液; (b)通过蒸馏分离有机溶剂-最后,使用水同时通过隔板将其混合;(c)添加基材以加速电子设备中B型残留溶液的形成; (四)离心,洗涤,干燥。

著录项

  • 公开/公告号AR035475A1

    专利类型

  • 公开/公告日2004-06-02

    原文格式PDF

  • 申请/专利权人 BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG;

    申请/专利号AR2000P100241

  • 发明设计人 DR. SCHNEIDER HEINRICH;

    申请日2000-01-19

  • 分类号C07D235/18;A61K31/4184;A61P9/12;A61P9/10;

  • 国家 AR

  • 入库时间 2022-08-21 23:12:21

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号